References
- Gan TJ . Poorly controlled postoperative pain: prevalence, consequences, and prevention. J. Pain Res.10, 2287–2298 (2017).
- Rawal N . Current issues in postoperative pain management. Eur. J. Anaesthesiol.33(3), 160–171 (2016).
- Birnie KA , ChambersCT , FernandezCVet al. Hospitalized children continue to report undertreated and preventable pain. Pain Res. Manag.19(4), 198–204 (2014).
- Garimella V , CelliniC. Postoperative pain control. Clin. Colon Rectal Surg.26(3), 191–196 (2013).
- Prabhakar A , MancusoKF , OwenCPet al. Perioperative analgesia outcomes and strategies. Best Pract. Res. Clin. Anaesthesiol.28(2), 105–115 (2014).
- Ottoboni T , QuartB , PawasauskasJ , DastaJF , PollakRA , ViscusiER. Mechanism of action of HTX-011: a novel, extended-release, dual-acting local anesthetic formulation for postoperative pain. Reg. Anesth. Pain Med.45(2), 117–123 (2020).
- Singla N , WinkleP , BertochT , HuJ , BeatonA , RedanJ. Opioid-free recovery after herniorrhaphy with HTX-011 as the foundation of a multimodal analgesic regimen. Surgery168(5), 915–920 (2020).
- Hah JM , BatemanBT , RatliffJ , CurtinC , SunE. Chronic opioid use after surgery: implications for perioperative management in the face of the opioid epidemic. Anesth. Analg.125(5), 1733–1740 (2017).
- Kaye AD , NovitchMB , CarlsonSFet al. The role of exparel plus meloxicam for postoperative pain management. Curr. Pain Headache Rep.24(3), 6 (2020).
- Moore RA , DerryS , McQuayHJ. Single dose oral meloxicam for acute postoperative pain in adults. Cochrane Database Syst. Rev.2009(4), CD007552 (2009).
- Sharpe KP , BerkowitzR , TyndallWAet al. Safety, tolerability, and effect on opioid use of meloxicam IV following orthopedic surgery. J. Pain Res.13, 221–229 (2020).
- Haas E , OnelE , MillerH , RagupathiM , WhitePF. A double-blind, randomized, active-controlled study for post-hemorrhoidectomy pain management with liposome bupivacaine, a novel local analgesic formulation. Am. Surg.78(5), 574–581 (2012).
- Prabhakar A , WardCT , WatsonMet al. Liposomal bupivacaine and novel local anesthetic formulations. Best Pract. Res. Clin. Anaesthesiol.33(4), 425–432 (2019).
- Hargreaves KKK . Local anesthetic failure in endodontics: mechanisms and management. Endod. Topics1, 26–39 (2002).
- Ottoboni T , GelderM , O’BoyleE. Biochronomer™ technology and the development of APF530, a sustained release formulation of granisetron. J. Exp. Pharmacol.6, 15–21 (2014).
- Lachiewicz PF , LeeG-C , PollakRA , LeimanDG , HuJ , SahAP. HTX-011 reduced pain and opioid use after primary total knee arthroplasty: results of a randomized Phase IIb Trial. J Arthroplasty35(10), 2843–2851 (2020).
- Strassels SA , ChenC , CarrDB. Postoperative analgesia: economics resource use, and patient satisfaction in an urban teaching hospital. Anesth. Analg.94(1), 130–7 (2002)
- Gan TJ , EpsteinRS , Leone-PerkinsML , SalimiT , IqbalSU , WhangPG. Practice patterns and treatment challenges in acute postoperative pain management: a survey of practicing physicians. Pain Ther.7(2), 205–216 (2018).
- Vadivelu N , MitraS , NarayanD. Recent advances in postoperative pain management. Yale J. Biol. Med.83(1), 11–25 (2010).
- Mitra S , SinatraRS. Perioperative management of acute pain in the opioid-dependent patient. Anesthesiology101(1), 212–227 (2004).
- Tang C , XiaZ. Dexmedetomidine in perioperative acute pain management: a non-opioid adjuvant analgesic. J. Pain Res.10, 1899–1904 (2017).
- Ventham NT , KennedyED , BradyRRet al. Efficacy of intravenous lidocaine for postoperative analgesia following laparoscopic surgery: a meta-analysis. World J. Surg.39(9), 2220–34 (2015)
- Brummett CM , WilliamsBA. Additives to local anesthetics for peripheral nerve blockade. Int. Anesthesiol. Clin.49(4), 104–116 (2011).
- Bagshaw KR , HanenbaumCL , CarboneEJet al. Pain management via local anesthetics and responsive hydrogels. Ther. Deliv.6(2), 165–76 (2015)
- Chahar P , CummingsKCIII. Liposomal bupivacaine: a review of a new bupivacaine formulation. J. Pain Res.5, 257–264 (2012).
- Elia N , LysakowskiC , TramèrMR. Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials. Anesthesiology103(6), 1296–1304 (2005).
- Viscusi E , GimbelJS , PollackRA , HuJ , LeeGC. HTX-011 reduced pain intensity and opioid consumption versus bupivacaine HCl in bunionectomy: Phase III results from the randomized EPOCH 1 study. Reg. Anesth. Pain Med.44(7), 700–706 (2019).
- Frey R , SalehS , BeckerC , MückW. Effects of age and sex on the pharmacokinetics of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521). Pulm. Circ.6(Suppl. 1), S58–S65 (2016).
- Hargreaves KM , KeiserK. Local anaesthetic failure in endodontics: mechanisms and management. Endod. Topics1, 26–39 (2002).
- Xu S , RouzerCA , MarnettLJ. Oxicams, a Class of NSAIDs and beyond. IUBMB66(12), 803–811 (2014).
- Distel M , BluhmkiE , MullerC , FriesJF. Safety of meloxicam: a global analysis of clinical trials. Rheumatology (Oxford)35(Suppl. 1), 68–77 (1996).
- INDICATIONS AND USAGE EXPAREL is indicated for single-dose infiltration in adults to produce postsurgical local analgesia and as an interscalene brachial plexus nerve block to produce postsurgical regional analgesia. Limitations of Use Safety and efficacy (2018). www.accessdata.fda.gov/drugsatfda_docs/label/2018/022496s9lbl.pdf
- Yamamoto A , OttoboniT , QuartB. Pharmacokinetics and safety of different bupivacaine formulations and administration techniques in augmentation mammoplasty. Presented at: ASHP Summer Meeting and Exhibition.MA, USA, (2019).
- Gantenbein M , AttoliniL , BruguerolleBet al. Oxidative metabolism of bupivacaine into pipecolylxylidine in humans is mainly catalyzed by CYP3A. Drug Metab. Dispos.28(4), 383–385 (2000).
- DiFazio CA . Metabolism of local anaesthetics in the fetus, newborn and adult. B Br. J. Anaesth.51(Suppl. 1), 295–345 (1979).
- Reynolds F . Metabolism and excretion of bupivacaine in man: a comparison with mepivacaine. Br. J. Anaesth.43(1), 33–37 (1971).
- Türck D , RothW , BuschU. A review of the clinical pharmacokinetics of meloxicam. Rheumatology (Oxford)35(Suppl. 1), 13–16 (1996).
- Mobic (meloxicam), prescribing information . (2000). www.accessdata.fda.gov/drugsatfda_docs/label/2016/020938s024s025,021530s014s015lbl.pdf
- Lachiewicz PF , LeeG-C , PollakRA , LeimanDG , HuJ , SahAP. HTX-011 reduced pain and opioid use after primary total knee arthroplasty: results of a randomized Phase IIb trial. J. Arthroplasty35(10), 2843–2851 (2020).
- Viscusi E , MinkowitzH , WinkleP , RamamoorthyS , HuJ , SinglaN. HTX-011 reduced pain intensity and opioid consumption versus bupivacaine HCl in herniorrhaphy: results from the Phase III EPOCH 2 study. Hernia23(6), 1071–1080 (2019).
- Heron Therapeutics Inc . ‘Heron Therapeutics receives European Commission Authorization for ZYNRELEF™ (HTX-011) for the treatment of postoperative pain | Heron Therapeutics’. https://herontherapeutics.gcs-web.com/news-releases/news-release-details/heron-therapeutics-receives-european-commission-authorization
- Source Heron Therapeutics Inc . ‘Heron Therapeutics receives positive CHMP opinion for ZYNRELEF™ (HTX-011) for the management of postoperative pain’. www.prnewswire.com/news-releases/heron-therapeutics-receives-positive-chmp-opinion-for-zynrelef-htx-011-for-the-management-of-postoperative-pain-301099292.html
- Source Heron Therapeutics Inc . ‘Heron Therapeutics receives complete response letter for HTX-011 for the Management of postoperative pain’. www.drugs.com/nda/htx_011_200629.html
- Source Heron Therapeutics Inc . ‘HTX-011 | Heron Therapeutics’. www.herontx.com/HTX-011